Tumor necrosis factor-related apoptosis-inducing ligand pathway and its therapeutic implications.
de Vries
Elisabeth G E
EG
Department of Medical Oncology, University of Groningen and University Medical Center, Groningen, The Netherlands. e.g.e.de.vries@int.umcg.nl
Gietema
Jourik A
JA
de Jong
Steven
S
D000818:Animals; D051017:Apoptosis Regulatory Proteins / Q000235:genetics / Q000502:physiology / Q000627:therapeutic use*; D006801:Humans; D008562:Membrane Glycoproteins / Q000235:genetics / Q000502:physiology / Q000627:therapeutic use*; D008954:Models, Biological; D009369:Neoplasms / Q000188:drug therapy / Q000503:physiopathology; D011994:Recombinant Proteins / Q000627:therapeutic use; D015398:Signal Transduction / Q000502:physiology*; D053221:TNF-Related Apoptosis-Inducing Ligand; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics / Q000502:physiology / Q000627:therapeutic use*
D051017:Apoptosis Regulatory Proteins; D008562:Membrane Glycoproteins; D011994:Recombinant Proteins; D053221:TNF-Related Apoptosis-Inducing Ligand; C505653:TNFSF10 protein, human; D014409:Tumor Necrosis Factor-alpha